Hiyoshi Yukiharu, Yoshida Naoya, Watanabe Masayuki, Kurashige Junji, Karashima Ryuichi, Iwagami Shiro, Baba Yoshifumi, Baba Hideo
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
Esophageal Surgery, Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of JFCR (Japanese Foundation for Cancer Research), Tokyo, Japan.
World J Surg. 2016 Apr;40(4):913-20. doi: 10.1007/s00268-015-3334-8.
Approximately 10-20 % of esophageal cancer patients in whom recurrence is diagnosed experience late recurrence beyond 2 years after esophagectomy. However, the risk of late recurrence is still unclear. The aim of this study was to identify the risk factors of late recurrence for appropriate postoperative surveillance.
A total of 447 patients underwent radical esophagectomy and reconstruction for esophageal cancer from 2005 to 2014. Patients who had recurrence beyond 2 years after esophagectomy were defined as the late recurrence group and the remaining patients with recurrence as the early recurrence group. A comparison of the clinicopathological factors and prognosis was performed between patients with early recurrence, late recurrence, and no recurrence.
Recurrences were recognized in 117(26.2 %) of the 447 patients. Recurrence was diagnosed within 2 years after surgery in 103 patients (88.0 %) and after 2 years in 14 patients (12.0 %). Patients with late recurrence showed a favorable prognosis compared with those with early recurrence (P = 0.0131), and late recurrence was an independent factor associated with a favorable prognosis after recurrence (HR 0.199, P = 0.025). In the comparison between patients with late recurrence and those with no recurrence who had a minimal recurrence-free survival of 2 years, pathological lymph node metastasis at esophagectomy was found to be an independent predictor of late recurrence (HR 7.296, P = 0.043).
Pathological lymph node metastasis at esophagectomy is a risk factor of late recurrence for esophageal cancer, and a close, lifelong follow-up is recommended for such patients.
在诊断为复发的食管癌患者中,约10%-20%会在食管切除术后2年以上出现晚期复发。然而,晚期复发的风险仍不明确。本研究的目的是确定晚期复发的风险因素,以便进行适当的术后监测。
2005年至2014年共有447例患者接受了食管癌根治性食管切除术和重建术。食管切除术后2年以上复发的患者被定义为晚期复发组,其余复发患者为早期复发组。对早期复发、晚期复发和无复发患者的临床病理因素及预后进行了比较。
447例患者中有117例(26.2%)出现复发。103例患者(88.0%)在术后2年内被诊断为复发,14例患者(12.0%)在术后2年后被诊断为复发。与早期复发患者相比,晚期复发患者的预后较好(P = 0.0131),晚期复发是复发后预后良好的独立相关因素(HR 0.199,P = 0.025)。在晚期复发患者与无复发且无复发生存期至少为2年的患者的比较中,发现食管切除时的病理淋巴结转移是晚期复发的独立预测因素(HR 7.296,P = 0.043)。
食管切除时的病理淋巴结转移是食管癌晚期复发的危险因素,建议对这类患者进行密切的终身随访。